Roche Holding AG Virtual Immunology/WCN Investor Event Transcript - Thomson StreetEvents

Roche Holding AG Virtual Immunology/WCN Investor Event Transcript

Roche Holding AG Virtual Immunology/WCN Investor Event Transcript - Thomson StreetEvents
Roche Holding AG Virtual Immunology/WCN Investor Event Transcript
Published Feb 07, 2025
14 pages (9810 words) — Published Feb 07, 2025
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of ROG.S conference call or presentation 7-Feb-25 3:30pm GMT

  
Brief Excerpt:

...Operator Ladies and gentlemen, welcome to Roche Virtual Immunology WCN Investor event. My name is Henrik, and I'm the technical operator for today's call. Kindly note that the webinar is being recorded. (Operator Instructions) At this time, it's a pleasure to introduce you to Bruno Ashley, Head of Investor Relations. Bruno, the stage is yours. Bruno Ashley ...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Roche Holding AG
Ticker
ROG.S
Time
3:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: James Quigley - Goldman Sachs - Analyst : Hi, Bruno, thanks for taking my questions. I've got a couple, please. So, first of all, where do you think the gas combination data will fit in the treatment paradigm? I know we shouldn't compare across trials, but the Bliss LN data looks similar in terms of placebo adjusted response, but lower infections. And of course, there are differences in baseline characteristics. REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. FEBRUARY 07, 2025 / 3:30PM, ROG.S - Roche Holding AG Virtual Immunology/WCN Investor Event So Assuming approval, you see two products on the market. So how will, Dr. Rovin, how will you and your colleagues choose between the two? And then the second question I had was, again, Ben Lita had a bit of a, an uptick when it had the looping device label, and also with the subcutaneous device. So are there plans for a gayver subcutaneous device in development? Thank you.

Question: James Quigley - Goldman Sachs - Analyst : Thank you. Can I follow up just quickly on that with Doctor Ron? So you mentioned about the gay of patients, being the B cell depleted for a long time. Roughly how long do they sort of stay B cell depleted? And is there any correlation from the data from Regency between sort of depth of response and B-cell depletion?

Question: James Quigley - Goldman Sachs - Analyst : Right. Thank you very much.

Table Of Contents

Roche Holding AG Hematology Update Transcript – 2025-06-23 – US$ 54.00 – Edited Transcript of ROG.S conference call or presentation 23-Jun-25 5:00pm GMT

Roche Holding AG Diagnostics Day Transcript – 2025-05-27 – US$ 54.00 – Edited Transcript of ROG.S corporate analyst meeting</ 27-May-25 12:00pm GMT

Q1 2025 Roche Holding AG Corporate Sales Call Transcript – 2025-04-24 – US$ 54.00 – Edited Transcript of ROG.S sales update conference call or presentation 24-Apr-25 12:00pm GMT

Roche Holding AG Neurology Update Virtual Event Transcript – 2025-04-04 – US$ 54.00 – Edited Transcript of ROG.S conference call or presentation 4-Apr-25 2:00pm GMT

Roche Holding AG Update on Sequencing Technology Presentation Transcript – 2025-02-20 – US$ 54.00 – Edited Transcript of ROG.S conference call or presentation 20-Feb-25 7:30pm GMT

Full Year 2024 Roche Holding AG Earnings Call Transcript – 2025-01-30 – US$ 54.00 – Edited Transcript of ROG.S earnings conference call or presentation 30-Jan-25 1:00pm GMT

Roche Holding AG IR Digitalization Day (Virtual) Transcript – 2024-11-25 – US$ 54.00 – Edited Transcript of ROG.S corporate analyst meeting</ 25-Nov-24 3:30pm GMT

Roche Holding AG Virtual Neurology Investor Event Transcript – 2024-10-31 – US$ 54.00 – Edited Transcript of ROG.S corporate analyst meeting</ 31-Oct-24 3:00pm GMT

Q3 2024 Roche Holding AG Corporate Sales Call Transcript – 2024-10-23 – US$ 54.00 – Edited Transcript of ROG.S sales update conference call or presentation 23-Oct-24 12:00pm GMT

Roche Holding AG Pharma Day Transcript – 2024-09-30 – US$ 54.00 – Edited Transcript of ROG.S corporate analyst meeting</ 30-Sep-24 8:30am GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Roche Holding AG Virtual Immunology/WCN Investor Event Transcript" Feb 07, 2025. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Roche-Holding-AG-Virtual-Immunology-WCN-Investor-Event-T16243526>
  
APA:
Thomson StreetEvents. (2025). Roche Holding AG Virtual Immunology/WCN Investor Event Transcript Feb 07, 2025. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Roche-Holding-AG-Virtual-Immunology-WCN-Investor-Event-T16243526>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.